Endoscopic treatment for distal malignant biliary obstruction

Area of Science:

• Gastroenterology
• Interventional Endoscopy
• Oncology

Background:

• Distal malignant biliary obstruction (MBO) causes jaundice, hepatic failure, and sepsis.
• Cholangitis complicates MBO, necessitating biliary drainage.
• Current practice often favors endoscopic biliary drainage (EBD) for initial MBO management.

Purpose of the Study:

• To review and compare different biliary drainage methods for malignant biliary obstruction.
• To evaluate stent choices (SEMS vs. PS, covered vs. uncovered) in various MBO scenarios.
• To guide treatment decisions when initial EBD fails or in unresectable cases.

Main Methods:

• Review of current biliary drainage techniques including surgical bypass, PTBD, EBD, and EUS-BD.
• Discussion of stent material and type selection based on resectability and previous treatment outcomes.
• Analysis of clinical scenarios for preoperative and unresectable MBO.

Main Results:

• EBD is a primary approach, but PTBD and EUS-BD are alternatives when EBD fails.
• Self-expandable metallic stents (SEMS) are generally preferred over plastic stents (PS).
• Covered SEMS are recommended for unresectable pancreatic cancer, while further research is needed for unresectable biliary tract cancer.

Conclusions:

• Treatment strategies for MBO vary based on EBD success, resectability, and institutional expertise.
• Optimal stent selection (covered vs. uncovered SEMS, SEMS vs. PS) requires further investigation for specific MBO types.
• EUS-guided biliary drainage offers a valuable alternative transgastrointestinal approach.